and early stage opportunities primarily in the Front Range of Colorado. His prior investments include Pyxis (acq. by Cardinal Health), Genomic Solutions (acq. by Harvard Bioscience), Tetra Technologies, Quovadx, and Myogen (acq. by Gilead Sciences, Inc)....
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Plato BioPharma, Inc Appoints New Board Member
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account